The University of Chicago Header Logo

Connection

Mark Talamonti to Dose-Response Relationship, Radiation

Back to Details
This is a "connection" page, showing publications Mark Talamonti has written about Dose-Response Relationship, Radiation.
Mark Talamonti
Connection Strength
0.047
Dose-Response Relationship, Radiation
  1. Eastern Cooperative Oncology Group Phase I trial of protracted venous infusion fluorouracil plus weekly gemcitabine with concurrent radiation therapy in patients with locally advanced pancreas cancer: a regimen with unexpected early toxicity. J Clin Oncol. 2000 Oct 01; 18(19):3384-9.
    View in: PubMed
    Score: 0.047
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.